HIGHLIGHTS
- who: Chan-Ping You et al. from the Department of Pathology, Rm, F, Block T, Queen Mary Hospital, Pokfulam Road, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Kong, Kong SAR, China have published the research work: Modulating the Activity of Androgen Receptor for Treating Breast Cancer, in the Journal: (JOURNAL)
- what: The suitable electronic sources used in the current review were identified from the PubMed database by searching the following key words: breast cancer; androgen receptor; targeted therapy; prognosis. In the trial, enzalutamide was used on advanced ERu03b1ve/AR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.